Neuroprotective Activity of pDING in Response to HIV-1 Tat

Journal of Cellular Physiology

Volumn 229, Issue 2, 2014, Pages 153-161

  Darbinian, Nune ^a   Khalili, Kamel ^a   Amini, Shohreh ^a,b  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Temple University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CASPASE 7; CYCLIN DEPENDENT KINASE 5; MITOGEN ACTIVATED PROTEIN KINASE; MYOCYTE ENHANCER FACTOR 2; NEUROPROTECTIVE AGENT; PLANT DING PROTEIN; SUPEROXIDE DISMUTASE; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELL PROLIFERATION; CELL STRUCTURE; CYTOTOXICITY; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN TISSUE; IMMUNOBLOTTING; MITOCHONDRIAL PERMEABILITY; NEUROPROTECTION; OXIDATIVE STRESS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

CELL DEATH; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE 5; HUMANS; HYPERICUM; MITOCHONDRIA; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; NEURONS; OXIDATIVE STRESS; PHOSPHATE-BINDING PROTEINS; PHOSPHORIC MONOESTER HYDROLASES; PLANT PROTEINS; TAT GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS;

EID: 84886301253     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.24392     Document Type: Article

References (43)

1. Akay C, Lindl KA, Wang Y, White MG, Isaacman-Beck J, Kolson DL, Jordan-Sciutto KL. 2011. Site-specific hyperphosphorylation of pRb in HIV-induced neurotoxicity. Mol Cell Neurosci 47:154-165.
2. Berridge MV, Herst PM, Tan AS. 2005. Tetrazolium dyes as tools in cell biology: New insights into their cellular reduction. Biotechnol Annu Rev 11:127-152.
3. Bookland MJ, Darbinian N, Weaver M, Amini S, Khalili K. 2012. Growth inhibition of malignant glioblastoma by DING protein. J Neurooncol 107:247-256.
4. Braunewell KH, Dwary AD, Richter F, Trappe K, Zhao C, Giegling I, Schönrath K, Rujescu D. 2011. Association of VSNL1 with schizophrenia, frontal cortical function, and biological significance for its gene product as a modulator of cAMP levels and neuronal morphology. Transl Psychiatry 1:e22.
5. Cheung ZH, Ip NY. 2012. Cdk5: A multifaceted kinase in neurodegenerative diseases. Trends Cell Biol 222:169-175.
6. Cheung ZH, Fu AK, Ip NY. 2006. Synaptic roles of Cdk5: Implications in higher cognitive functions and neurodegenerative diseases. Neuron 50:13-18.
7. Cox DM, Du M, Marback M, Yang EC, Chan J, Siu KW, McDermott JC. 2003. Phosphorylation motifs regulating the stability and function of myocyte enhancer factor 2A. J Biol Chem 278:15297-15303.
8. Darbinian N, Popov Y, Khalili K, Amini S. 2008. Creation of a bi-directional protein transduction system for suppression of HIV-1 expression by p27SJ. Antiviral Res 79:136-141.
9. Darbinian N, Czernik M, Darbinyan A, Elias M, Chabriere E, Bonasu S, Khalili K, Amini S. 2009. Evidence for phosphatase activity of p27SJ and its impact on the cell cycle. J Cell Biochem 107:400-407.
10. Darbinian N, Gomberg R, Mullen L, Garcia S, White MK, Khalili K, Amini S. 2011. Suppression of HIV-1 transcriptional elongation by a DING phosphatase. J Cell Biochem 112:225-232.
11. Darbinian-Sarkissian N, Darbinyan A, Otte J, Radhakrishnan S, Sawaya BE, Arzumanyan A, Chipitsyna G, Popov Y, Rappaport J, Amini S, Khalili K. 2006. p27(SJ), a novel protein in St John's Wort, that suppresses expression of HIV-1 genome. Gene Ther 13:288-295.
12. Finegan KG, Wang X, Lee E-J, Robinson AC, Tournier C. 2009. Regulation of neuronal survival by the extracellular signal-regulated protein kinase 5. Cell Death Differ 16:674-683.
13. Fiore R, Khudayberdiev S, Christensen M, Siegel G, Flavell SW, Kim TK, Greenberg ME, Schratt G. 2009. Mef2-mediated transcription of the miR 379-410 cluster regulates activity-dependent dendritogenesis by fine-tuning Pumilio2 protein levels. EMBO J 28:697-710.
14. Flavell SW, Cowan CW, Kim TK, Greer PL, Lin Y, Paradis S, Griffith EC, Hu LS, Chen C, Greenberg ME. 2006. Activity-dependent regulation of MEF2 transcription factors suppresses excitatory synapse number. Science 311:1008-1012.
15. Flavell SW, Greenberg ME. 2008. Signaling mechanisms linking neuronal activity to gene expression and plasticity of the nervous system. Annu Rev Neurosci 31:563-590.
16. Flavell SW, Kim TK, Gray JM, Harmin DA, Hemberg M, Hong EJ, Markenscoff-Papadimitriou E, Bear DM, Greenberg ME. 2008. Genome-wide analysis of MEF2 transcriptional program reveals synaptic target genes and neuronal activity-dependent polyadenylation site selection. Neuron 60:1022-1038.
17. Galluzzi L, Blomgren K, Kroemer G. 2009. Mitochondrial membrane permeabilization in neuronal injury. Nat Rev Neurosci 10:481-494.
18. Gong X, Tang X, Wiedmann M, Wang X, Peng J, Zheng D, Blair LA, Marshall J, Mao Z. 2003. Cdk5-mediated inhibition of the protective effects of transcription factor MEF2 in neurotoxicity-induced apoptosis. Cdk5-mediated inhibition of the protective effects of transcription factor MEF2 in neurotoxicity-induced apoptosis. Neuron 38:33-46.
19. Gras G, Kaul M. 2010. Molecular mechanisms of neuroinvasion by monocytes-macrophages in HIV-1 infection. Retrovirology 7:30.
20. Grégoire S, Tremblay AM, Xiao L, Yang Q, Ma K, Nie J, Mao Z, Wu Z, Giguère V, Yang XJ. 2006. Control of MEF2 transcriptional activity by coordinated phosphorylation and sumoylation. J Biol Chem 281:4423-4433. Erratum in: J Biol Chem. 2006. 281:8996.
21. Homma N, Takei Y, Tanaka Y, Nakata T, Terada S, Kikkawa M, Noda Y, Hirokawa N. 2003. Kinesin superfamily protein 2A (KIF2A) functions in suppression of collateral branch extension. Cell 114:229-239.
22. Jan YN, Jan LY. 2010. Branching out: Mechanisms of dendritic arborization. Nat Rev Neurosci 11:316-328.
23. Kaul M. 2008. HIV's double strike at the brain: Neuronal toxicity and compromised neurogenesis. Front Biosci 13:2484-2494.
24. Kaul M, Lipton SA. 2006. Mechanisms of neuroimmunity and neurodegeneration associated with HIV-1 infection and AIDS. J Neuroimmune Pharmacol 1:138-151.
25. King JE, Eugenin EA, Buckner CM, Berman JW. 2006. HIV tat and neurotoxicity. Microbes Infect 8:1347-1357.
26. Li W, Galey D, Mattson MP, Nath A. 2005. Molecular and cellular mechanisms of neuronal cell death in HIV dementia. Neurotox Res 8:119-134.
27. Li W, Li G, Steiner J, Nath A. 2009. Role of Tat protein in HIV neuropathogenesis. Neurotox Res 16:205-220.
28. Mao Z, Bonni A, Xia F, Nadal-Vicens M, Greenberg ME. 1999. Neuronal activity-dependent cell survival mediated by transcription factor MEF2. Science 286:785-790.
29. McKinsey TA, Zhang CL, Olson EN. 2002. MEF2: A calcium-dependent regulator of cell division, differentiation and death. Trends Biochem Sci 27:40-47. Erratum in: Trends Biochem Sci. 2002. 57:271.
30. Medders KE, Kaul M. 2011. Mitogen-activated protein kinase p38 in HIV infection and associated brain injury. J Neuroimmune Pharmacol 6:202-215.
31. Pazyra-Murphy MF, Hans A, Courchesne SL, Karch C, Cosker KE, Heerssen HM, Watson FL, Kim T, Greenberg ME, Segal RA. 2009. A retrograde neuronal survival response: Target-derived neurotrophins regulate MEF2D and bcl-w. J Neurosci 29:6700-6709.
32. Ramachandran B, Yu G, Li S, Zhu B, Gulick T. 2008. Myocyte enhancer factor 2A is transcriptionally autoregulated. J Biol Chem 283:10318-10329.
33. Sala C, Piëch V, Wilson NR, Passafaro M, Liu G, Sheng M. 2001. Regulation of dendritic spine morphology and synaptic function by Shank and Homer. Neuron 31:115-130.
34. Shalizi AK, Bonni A. 2005. Brawn for brains: The role of MEF2 proteins in the developing nervous system. Curr Top Dev Biol 69:239-266.
35. Singh IN, El-Hage N, Campbell ME, Lutz SE, Knapp PE, Nath A, Hauser KF. 2005. Differential involvement of p38 and JNK MAP kinases in HIV-1 Tat and gp120-induced apoptosis and neurite degeneration in striatal neurons. Neuroscience 135:781-790.
36. Smith PD, Mount MP, Shree R, Callaghan S, Slack RS, Anisman H, Vincent I, Wang X, Mao Z, Park DS. 2006. Calpain-regulated p35/cdk5 plays a central role in dopaminergic neuron death through modulation of the transcription factor myocyte enhancer factor 2. J Neurosci 26:440-447.
37. Tian X, Kai L, Hockberger PE, Wokosin DL, Surmeier DJ. 2010. MEF2 regulates activity-dependent spine loss in striatopallidal medium spiny neurons. Mol Cell Neurosci 44:94-108.
38. Tang X, Wang X, Gong X, Tong M, Park D, Xia Z, Mao Z. 2005. Cyclin-dependent kinase 5 mediates neurotoxin-induced degradation of the transcription factor myocyte enhancer factor 2. J Neurosci 25:4823-4834.
39. Wang Y, White MG, Akay C, Chodroff RA, Robinson J, Lindl KA, Dichter MA, Qian Y, Mao Z, Kolson DL, Jordan-Sciutto KL. 2007. Activation of cyclin-dependent kinase 5 by calpains contributes to human immunodeficiency virus-induced neurotoxicity. J Neurochem 103:439-455.
40. Yadav A, Collman RG. 2009. CNS inflammation and macrophage/microglial biology associated with HIV-1 infection. J Neuroimmune Pharmacol 4:430-447.
41. Yanni PA, Lindsley TA. 2000. Ethanol inhibits development of dendrites and synapses in rat hippocampal pyramidal neuron cultures. Dev Brain Res 120:233-243.
42. Yelamanchili SV, Chaudhuri AD, Chen LN, Xiong H, Fox HS. 2010. MicroRNA-21 dysregulates the expression of MEF2C in neurons in monkey and human SIV/HIV neurological disease. Cell Death Dis 1:e77.
43. Zhao M, New L, Kravchenko VV, Kato Y, Gram H, di Padova F, Olson EN, Ulevitch RJ, Han J. 1999. Regulation of the MEF2 family of transcription factors by p38. Mol Cell Biol 19:21-30.